Tuberculosis

13 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Infections

Narrower: Latent Tuberculosis 3, Tuberculosis, Lymph Node 1, Tuberculosis, Multidrug-Resistant 3

Treatments and conditions

Tuberculosis
Treatment and conditionWhere it standsTrials
Bacillus calmette-guerin live antigen, unspecified substrain for tuberculosisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Bedaquiline for tuberculosis, multidrug-resistantPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Blmz for tuberculosis, multidrug-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
BPaLMZ Regimen for latent tuberculosisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Dolutegravir + Isoniazid + RIFAPENTINE for latent tuberculosisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Isoniazid + RIFAPENTINE for latent tuberculosisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)2
M72/AS01E-4 Mycobacterium tuberculosis investigational vaccine for tuberculosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Metformin for tuberculosisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Moxifloxacin + rifapentine for tuberculosis, lymph nodePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Mtbvac for tuberculosisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
N-Acetylcysteine (NAC) Treatment for tuberculosisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for tuberculosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Quabodepistat for tuberculosis, multidrug-resistantPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.